Adam J. Gordon

11.2k total citations · 1 hit paper
322 papers, 7.4k citations indexed

About

Adam J. Gordon is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and General Health Professions. According to data from OpenAlex, Adam J. Gordon has authored 322 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Public Health, Environmental and Occupational Health, 148 papers in Epidemiology and 117 papers in General Health Professions. Recurrent topics in Adam J. Gordon's work include Opioid Use Disorder Treatment (183 papers), Substance Abuse Treatment and Outcomes (111 papers) and HIV, Drug Use, Sexual Risk (60 papers). Adam J. Gordon is often cited by papers focused on Opioid Use Disorder Treatment (183 papers), Substance Abuse Treatment and Outcomes (111 papers) and HIV, Drug Use, Sexual Risk (60 papers). Adam J. Gordon collaborates with scholars based in United States, United Kingdom and Canada. Adam J. Gordon's co-authors include Amy C. Justice, Bradley D. Stein, David A. Fiellin, Kevin L. Kraemer, Joseph Conigliaro, Kathleen A. McGinnis, Mark Sorbero, Andrew W. Dick, Kendall Bryant and Rosalie Liccardo Pacula and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Adam J. Gordon

298 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation

2020 157 citations Stefan G. Kertesz, Adam J. Gordon et al. profile →

Peers

Countries citing papers authored by Adam J. Gordon

Since Specialization

Citations

This map shows the geographic impact of Adam J. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Gordon more than expected).

Fields of papers citing papers by Adam J. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Gordon. The network helps show where Adam J. Gordon may publish in the future.

Co-authorship network of co-authors of Adam J. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Adam J. Gordon. A scholar is included among the top collaborators of Adam J. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam J. Gordon. Adam J. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Buprenorphine Treatment for Opioid Use Disorder in Non–Addiction Specialty Settings 2025 ·JAMA Network Open ·(unknown), Audrey L. Jones, Hongwei Zhao, Richard E. Nelson, Hildi Hagedorn, Eric J. Hawkins, Adam J. Gordon	0
2	Protocol for research examination of individual suicides occurring in chronic pain: A qualitative approach to psychological autopsy methodology 2025 ·PLoS ONE ·Stefan G. Kertesz, Allyson L. Varley, (unknown), Thomas E. Joiner, Beth D. Darnall, (unknown), (unknown), M. Gilmore, Kevin R. Riggs, Stephanie A. Gamble, Adam J. Gordon, Yogesh Dwivedi, (unknown), Christin Veasley, Chad M. Patton, (unknown), David Gibson, James M. Elliott, Megan B. McCullough	0
3	Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women 2025 ·Journal of Addiction Medicine ·(unknown), (unknown), Stefan G. Kertesz, Lillian Gelberg, Adam J. Gordon, Audrey L. Jones	0
4	Prevention of postpartum methamphetamine use with micronized progesterone trial (PROMPT): A pilot randomized controlled trial protocol 2024 ·Contemporary Clinical Trials Communications ·Marcela C. Smid, (unknown), (unknown), (unknown), (unknown), (unknown), Amanda A. Allshouse, Elizabeth Turner, (unknown), Marie J. Gibson, Adam J. Gordon, Gerald Cochran	0
5	Expert Panel Consensus on the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders 2024 ·Journal of Addiction Medicine ·(unknown), (unknown), (unknown), Sean Grant, Stefan G. Kertesz, Adam J. Gordon	0
6	Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder 2024 ·Journal of Addiction Medicine ·Jessica J. Wyse, (unknown), (unknown), Adam J. Gordon, (unknown), Travis I. Lovejoy, Katherine Mackey, Benjamin J. Morasco	4
7	Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder 2023 ·SHILAP Revista de lepidopterología ·(unknown), Mark Bounthavong, Adam J. Gordon, Allison M. Gustavson, (unknown), W Miller, (unknown), Princess E. Ackland, Barbara Clothier, Ann Bangerter, Siamak Noorbaloochi, Alex H. S. Harris, Hildi Hagedorn	3
8	Patient-Centered Quality Measurement for Opioid Use Disorder: Development of a Taxonomy to Address Gaps in Research and Practice 2022 ·Substance Abuse ·A. Taylor Kelley, (unknown), (unknown), (unknown), Saul J. Weiner, Susan Zickmund, Audrey L. Jones, Megan E. Vanneman, Molly B. Conroy, Adam J. Gordon, John F. P. Bridges	13
9	Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C 2022 ·The American Journal of Drug and Alcohol Abuse ·Barbara Andraka‐Christou, Brendan Saloner, Adam J. Gordon, Rachel Totaram, (unknown), (unknown), Bradley D. Stein	12
10	Changes in predicted opioid overdose risk over time in a state Medicaid program: a group‐based trajectory modeling analysis 2022 ·Addiction ·Jingchuan Guo, Walid F. Gellad, (unknown), Jeremy C. Weiss, Julie M. Donohue, Gerald Cochran, Adam J. Gordon, Daniel C. Malone, C. Kent Kwoh, Courtney C. Kuza, Debbie L. Wilson, Wei‐Hsuan Lo‐Ciganic	4
11	Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine 2022 ·Substance Abuse ·(unknown), Jonathan Levin, Brendan Saloner, Adam J. Gordon, Andrew W. Dick, Tisamarie B. Sherry, Douglas Leslie, Mark Sorbero, Bradley D. Stein	16
12	Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention 2022 ·Journal of General Internal Medicine ·Bradley D. Stein, (unknown), Flora Sheng, Brendan Saloner, Adam J. Gordon, Mark Sorbero, Andrew W. Dick	11
13	Commentary Article: Opioid use Disorder Cascade of Care Framework Design: A Roadmap 2022 ·Substance Abuse ·Arthur Robin Williams, Kimberly Johnson, Cindy Parks Thomas, Sharon Reif, M. Eugenia Socías, Brandy F. Henry, Charles J. Neighbors, Adam J. Gordon, Constance M. Horgan, Bohdan Nosyk, Karen Drexler, Noa Krawczyk, Gregg Gonsalves, Scott E. Hadland, Bradley D. Stein, Marc Fishman, A. Taylor Kelley, Harold Alan Pincus, Mark Olfson	19
14	The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline 2022 ·Annals of Internal Medicine ·(unknown), Joseph Liberto, (unknown), (unknown), Hildi Hagedorn, Timothy Atkinson, James R. McKay, Larissa J. Mooney, James Sall, (unknown), (unknown), Christopher Spevak, Adam J. Gordon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	37
15	Perioperative Management of Extended-release Buprenorphine 2022 ·Journal of Addiction Medicine ·(unknown), Jonathan T. Henry, Ellen L. Edens, Adam J. Gordon, (unknown)	5
16	Does Reducing Drinking in Patients with Unhealthy Alcohol Use Improve Pain Interference, Use of Other Substances, and Psychiatric Symptoms? 2020 ·Alcoholism Clinical and Experimental Research ·Ellen C. Caniglia, Elizabeth R. Stevens, Maria R. Khan, (unknown), (unknown), Brandon D. L. Marshall, Natalie E. Chichetto, Julie R. Gaither, Stephen Crystal, E. Jennifer Edelman, David A. Fiellin, Adam J. Gordon, Kendall Bryant, Janet Tate, Amy C. Justice, R. Scott Braithwaite	10
17	A Population-Based Examination of Trends and Disparities in Medication Treatment for Opioid use Disorders among Medicaid Enrollees 2018 ·Substance Abuse ·Bradley D. Stein, Andrew W. Dick, Mark Sorbero, Adam J. Gordon, Rachel M. Burns, Douglas Leslie, Rosalie Liccardo Pacula	92
18	Receipt of Opioid Analgesics by HIV-Infected and Uninfected Patients 2012 ·Journal of General Internal Medicine ·E. Jennifer Edelman, Kirsha S. Gordon, William C. Becker, Joseph L. Goulet, Melissa Skanderson, Julie R. Gaither, Jennifer Brennan Braden, Adam J. Gordon, Robert D. Kerns, Amy C. Justice, David A. Fiellin	95
19	Alcohol Problems and Health Care Services Use in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Veterans 2006 ·Medical Care ·Kevin L. Kraemer, Kathleen A. McGinnis, Melissa Skanderson, Rob Cook, Adam J. Gordon, Joseph Conigliaro, Yujing Shen, David A. Fiellin, Amy C. Justice	34
20	Physician Participation in Human Rights Abuses in Southern Iraq 2004 ·JAMA ·Bevanne Bean‐Mayberry, Adam J. Gordon, Shawn L. Fultz, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact